Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hendrik Fuchs

Showing results (41-50 of 100) with videos related to

Pageof 10
Sort By:
Cancer Biology & Therapy|December 7, 2007
Chimeric toxins inhibit growth of primary oral squamous cell carcinoma cellsChristopher Bachran, Iring Heisler, Diana Bachran, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 7, 2005
Combined application of saponin and chimeric toxins drastically enhances the targeted cytotoxicity on tumor cellsIring Heisler, Mark Sutherland, Christopher Bachran, et al.
Science Advances|October 21, 2022
Unexpected significance of a minor reaction pathway in daytime formation of biogenic highly oxygenated organic compoundsHongru Shen, Luc Vereecken, Sungah Kang, et al.
Bioprocess and Biosystems Engineering|February 7, 2008
Production of bifunctional single-chain antibody-based fusion proteins in Pichia pastoris supernatantsHossein Panjideh, Vânia Coelho, Jens Dernedde, et al.
Current Pharmaceutical Design|October 25, 2014
Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacyRoger Gilabert-Oriol, Alexander Weng, Benedicta von Mallinckrodt, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 16, 2012
Targeted tumor therapy with a fusion protein of an antiangiogenic human recombinant scFv and yeast cytosine deaminaseNicole Schellmann, Hossein Panjideh, Patricia Fasold, et al.
Protein Expression and Purification|July 23, 2013
Small structural differences of targeted anti-tumor toxins result in strong variation of protein expressionRoger Gilabert-Oriol, Mayank Thakur, Christoph Weise, et al.
Electrophoresis|October 15, 2011
Electrophoretic isolation of saponin fractions from Saponinum album and their evaluation in synergistically enhancing the receptor-specific cytotoxicity of targeted toxinsMayank Thakur, Alexander Weng, Diana Bachran, et al.
Nanomaterials (Basel, Switzerland)|April 30, 2021
Magnetic Nanoparticle-Based Dianthin Targeting for Controlled Drug Release Using the Endosomal Escape Enhancer SO1861Ajmal Zarinwall, Mazdak Asadian-Birjand, Didem Ag Seleci, et al.
Journal of Cancer|October 20, 2023
Synergistic Cytotoxicity of a Toxin Targeting the Epidermal Growth Factor Receptor and the Glycosylated Triterpenoid SO1861 in Prostate CancerAlexandra Fischer, Anie Priscilla Masilamani, Susanne Schultze-Seemann, et al.
Pageof 10

Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
Cancer Biology & Therapy|December 7, 2007
Chimeric toxins inhibit growth of primary oral squamous cell carcinoma cellsChristopher Bachran, Iring Heisler, Diana Bachran, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 7, 2005
Combined application of saponin and chimeric toxins drastically enhances the targeted cytotoxicity on tumor cellsIring Heisler, Mark Sutherland, Christopher Bachran, et al.
Science Advances|October 21, 2022
Unexpected significance of a minor reaction pathway in daytime formation of biogenic highly oxygenated organic compoundsHongru Shen, Luc Vereecken, Sungah Kang, et al.
Bioprocess and Biosystems Engineering|February 7, 2008
Production of bifunctional single-chain antibody-based fusion proteins in Pichia pastoris supernatantsHossein Panjideh, Vânia Coelho, Jens Dernedde, et al.
Current Pharmaceutical Design|October 25, 2014
Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacyRoger Gilabert-Oriol, Alexander Weng, Benedicta von Mallinckrodt, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 16, 2012
Targeted tumor therapy with a fusion protein of an antiangiogenic human recombinant scFv and yeast cytosine deaminaseNicole Schellmann, Hossein Panjideh, Patricia Fasold, et al.
Protein Expression and Purification|July 23, 2013
Small structural differences of targeted anti-tumor toxins result in strong variation of protein expressionRoger Gilabert-Oriol, Mayank Thakur, Christoph Weise, et al.
Electrophoresis|October 15, 2011
Electrophoretic isolation of saponin fractions from Saponinum album and their evaluation in synergistically enhancing the receptor-specific cytotoxicity of targeted toxinsMayank Thakur, Alexander Weng, Diana Bachran, et al.
Nanomaterials (Basel, Switzerland)|April 30, 2021
Magnetic Nanoparticle-Based Dianthin Targeting for Controlled Drug Release Using the Endosomal Escape Enhancer SO1861Ajmal Zarinwall, Mazdak Asadian-Birjand, Didem Ag Seleci, et al.
Journal of Cancer|October 20, 2023
Synergistic Cytotoxicity of a Toxin Targeting the Epidermal Growth Factor Receptor and the Glycosylated Triterpenoid SO1861 in Prostate CancerAlexandra Fischer, Anie Priscilla Masilamani, Susanne Schultze-Seemann, et al.
Pageof 10